Antimicrobial drug resistance is a global health problem that continues to expand as micro-organisms adapt to the antibiotics we use to treat them and as new classes of antimicrobial agents have been harder to discover and advance into the clinic. The second edition of Antimicrobial Drug Resistance grew out of a desire by the editors and authors to provide an
updated, comprehensive resource of information on antimicrobial drug resistance that would
encompass the current information available for bacteria, fungi, protozoa, and viruses. The two volumes have been extensively revised with many new authors and chapters as the field of drug resistance has evolved. We believe that this information will be of value to clinicians, epidemiologists, microbiologists, virologists, parasitologists, public health authorities, medical students, and fellows in training.
We have endeavored to provide this information in a style that is accessible to the broad community of persons who are concerned with the impact of drug resistance in our clinics and across broader global communities. Antimicrobial Drug Resistance is divided into two volumes.
Part VII: Gram Positive Bacterial Drug Resistance: Clinical
Part VIII: Gram Negative Bacterial Drug Resistance: Clinical
Part IX: Fungal Drug Resistance: Clinical
Part X: Viral Drug Resistance: Clinical
Part XI: Parasitic Drug Resistance: Clinical
Part XIII: Public Health Issues of Drug Resistance
Title: “Antimicrobial Drug Resistance Clinical and Epidemiological Aspects, Volume 2”
Author: “Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim”
Volume: 2do volume